Corrigendum to ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa [Cytotherapy 25 (2023) 782–788/1562, (S1465324923000361), (10.1016/j.jcyt.2023.01.015)]

Kathrin Dieter, Elke Niebergall-Roth, Cristina Daniele, Silvia Fluhr, Natasha Y. Frank, Christoph Ganss, Dimitra Kiritsi, John A. McGrath, Jakub Tolar, Markus H. Frank, Mark A. Kluth

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors regret that the following funding information was missed: Contributions by JT to this work were supported by National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grant #R01AR063070. The authors would like to apologize for any inconvenience caused.

Original languageEnglish
Pages (from-to)1016
Number of pages1
JournalCytotherapy
Volume25
Issue number9
DOIs
Publication statusPublished - 2023 Sept

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Genetics(clinical)
  • Cell Biology
  • Transplantation
  • Cancer Research

Fingerprint

Dive into the research topics of 'Corrigendum to ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa [Cytotherapy 25 (2023) 782–788/1562, (S1465324923000361), (10.1016/j.jcyt.2023.01.015)]'. Together they form a unique fingerprint.

Cite this